An increasing prevalence of degenerative diseases and lower back pain will drive the global lateral lumbar interbody fusion market, according to a Transparency Market Research analysis.
Here are six observations:
1. Another market driver is enhanced visualization technologies, which offers a simpler and more precise procedure.
2. Minimally invasive lateral lumbar interbody fusion is gaining popularity, due to outcomes involving enhanced spine alignment, less blood loss and less tissue damage.
3. The costliness of lateral lumbar interbody fusions may deter market growth, though.
4. Additionally, several lateral lumbar interbody fusion risks exist, such as psoas muscle or neural network injury and bone graft fusion complications.
5. North America leads the global market, due to technological advancements, research and development investments and improved healthcare infrastructure.
6. Dominant market players include:
• DePuy Synthes in Raynham, Mass.
• NuVasive in San Diego
• Stryker Corp. in Kalamazoo, Mich.
• Smith & Nephew in London, United Kingdom
• Medtronic in Dublin, Ireland
• Paradigm Spine in New York City
• Alphatec Spine in Carlsbad, Calif.
More articles on spine:
Alphatec Spine welcomes 2 executives to sales leadership team — 4 takeaways
Rubber-like fibers may prove helpful to spinal cord injury recovery: 5 things to know
Mississippi health system eliminates neurosurgery services in financial dip — 4 insights